Document and Entity Information
| Document and Entity Information | Aug. 27, 2025 |
| Cover [Abstract] | |
| Amendment Flag | false |
| Entity Central Index Key | 0001175505 |
| Document Type | 8-K |
| Document Period End Date | Aug. 27, 2020 |
| Entity Registrant Name | Five Prime Therapeutics, Inc. |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-36070 |
| Entity Tax Identification Number | 26-0038620 |
| Entity Address, Address Line One | 111 Oyster Point Boulevard |
| Entity Address, City or Town | South San Francisco |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94080 |
| City Area Code | (415) |
| Local Phone Number | 365-5600 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, par value $0.001 per share |
| Trading Symbol | FPRX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |